Woman and Man | Between 18 years et 75 years
- | Country :
- France
- | organs :
- Peau - autres
- | Specialty :
- Autres (cryothérapie, radiofréquence, homéopathie,...)
Extract
A multicenter, randomised, double-blind, placebo controlled, phase II study to evaluate the safety and efficacy of subcutaneous bioresorbable implants of afamelanotide (CUV1647) for the prophylactic treatment of pre-cancerous skin lesions of the head, forearms and hands in immune compromised, organ transplant patients.
Scientific Abstract
en cours d'intégration;